Reese Poncia
Subscribe to Reese Poncia's PostsMarisa (Reese) E. Poncia focuses her practice on antitrust matters and competition law, including antitrust litigation and compliance matters, as well as mergers and acquisitions (M&A) transactions. Read Reese Poncia's full bio.
Antitrust M&A Snapshot | Q1 2024
By Reese Poncia, Julian Rößler-Weis, Jon B. Dubrow, Joel R. Grosberg, Stéphane Dionnet, Graham Hyman and Max Küttner on May 2, 2024
Posted In Cartel Enforcement, DOJ Developments, EC Developments, EU Developments, FTC Developments, Healthcare Antitrust, Mergers & Acquisitions
Topics covered in this edition: The Federal Trade Commission (FTC) and US Department of Justice have begun implementing the 2023 Merger Guidelines in their enforcement actions During a virtual workshop, the FTC highlighted its focus on private equity (PE) acquisitions of healthcare service providers and expressed concerns about PE in healthcare Artificial intelligence’s antitrust implications...
Continue Reading
Heard at the 2024 Antitrust Law Section Spring Meeting: Part II
By Lisa P. Rumin, Anthony S. Ferrara, Reese Poncia, Noah Feldman Greene, Zachary Sproull, Han Cui, Graham Hyman, Glenna Siegel, Alex Grayson, Betty Zhang and Gregory E. Heltzer on Apr 12, 2024
Posted In Agriculture, DOJ Developments, FTC Developments, Healthcare Antitrust, Mergers & Acquisitions, Monopolization/Abuse of Dominance
The American Bar Association Antitrust Law Section’s annual Spring Meeting concluded on April 12. The annual Spring Meeting featured updates from federal, state and international antitrust enforcers and extensive discussion on priority antitrust issues affecting various industries. In this article, we highlight takeaways from the final two days of the Spring Meeting. Read more here.
Continue Reading
Heard at the 2024 Antitrust Law Section Spring Meeting: Part I
By Gregory E. Heltzer, Lisa P. Rumin, Reese Poncia, Anthony S. Ferrara, Claire Danberg, Glenna Siegel, Bailey K. Sanders, Betty Zhang and Alex Grayson on Apr 11, 2024
Posted In DOJ Developments, FTC Developments, Healthcare Antitrust, Mergers & Acquisitions, Monopolization/Abuse of Dominance
The American Bar Association Antitrust Law Section’s annual Spring Meeting is underway in Washington, DC. The annual Spring Meeting features updates from federal, state and international antitrust enforcers and extensive discussion on priority antitrust issues affecting various industries. In this article, we highlight the key takeaways from the first portion of the Spring Meeting. Read...
Continue Reading
Cartel Corner | July 2023
By Justin P. Murphy, Paul M. Thompson, Stéphane Dionnet, Han Cui, Reese Poncia, Alexandra Lewis, Graham Hyman, Nabil Lakhal, Glenna Siegel and Bailey K. Sanders on Jul 13, 2023
Posted In Cartel Enforcement, DOJ Developments, EC Developments, EU Developments, FTC Developments, Monopolization/Abuse of Dominance
In the first half of 2023, antitrust enforcers remained remarkably busy both in the United States (US) and across the European Union (EU). The US Department of Justice’s (DOJ’s) Antitrust Division (Division) and the Federal Trade Commission (FTC) have continued their aggressive and novel effort to drag antitrust enforcement into the labor markets. The DOJ...
Continue Reading
Going ‘Green’—What Does That Mean? FTC Proposes Revisions to Green Guides
By Lesli Esposito and Reese Poncia on Jun 2, 2023
Posted In Consumer Protection/Privacy, FTC Developments
With growing consumer demand for environmentally friendly products and services, businesses are ramping up their “green” advertising endeavors to showcase eco-friendly credentials like carbon emissions reductions, renewable energy and recycled materials. In light of this surge in “going green” marketing, the Federal Trade Commission (FTC) has proposed revisions to its Guides for Use of Environmental...
Continue Reading
Negative Option Offers: How the FTC’s Proposed Rule Could Affect Your Business
By Lesli Esposito and Reese Poncia on Apr 26, 2023
Posted In Consumer Protection/Privacy, FTC Developments
In March 2023, the Federal Trade Commission (FTC) proposed tightened requirements of the Negative Option Rule. This is an effort to combat unfair or deceptive practices, such as charging customers for recurring products or services that they don’t want and can’t cancel easily. Negative options refer to features like automatic renewals, prenotification plans, free-to-pay and...
Continue Reading
Heard at the 2023 Spring Meeting: Part 2
By Gregory E. Heltzer, Lisa P. Rumin, Reese Poncia, Joshua W. Eastby, Graham Hyman, Claire Danberg, Bailey K. Sanders, William Paige and Glenna Siegel on Apr 5, 2023
Posted In Consumer Protection/Privacy, DOJ Developments, FTC Developments, Healthcare Antitrust, Mergers & Acquisitions, Monopolization/Abuse of Dominance
The American Bar Association’s Antitrust Law Section held its annual Spring Meeting in Washington, DC, on March 29–31, 2023. The Spring Meeting sessions featured updates from federal, state, and international antitrust enforcers and thought-invoking discussions on leading antitrust issues facing the business community today. Following Part 1, this post summarizes key takeaways from the second...
Continue Reading
Heard at the 2023 Spring Meeting: Part 1
By Gregory E. Heltzer, Lisa P. Rumin, Reese Poncia, Joshua W. Eastby, Glenna Siegel, Bailey K. Sanders, Claire Danberg, Graham Hyman and William Paige on Apr 3, 2023
Posted In DOJ Developments, FTC Developments, Healthcare Antitrust, Mergers & Acquisitions, Monopolization/Abuse of Dominance
The American Bar Association’s Antitrust Law Section recently held its annual Spring Meeting in Washington, DC, featuring updates from federal, state, and international antitrust enforcers and in-depth commentary on leading antitrust issues facing the business community today. This post recaps key takeaways from the first portion of the Spring Meeting. CIVIL ENFORCEMENT AND MERGER REVIEW:...
Continue Reading
Customer Reviews: Five-Star Enforcement and the Expanding Regulations
By Lesli Esposito and Reese Poncia on Feb 28, 2023
Posted In Consumer Protection/Privacy, DOJ Developments, FTC Developments
Does your company sell to consumers or businesses that can leave reviews or rate your products? Whether your customers can leave reviews on your website or another public-facing review platform, companies should be aware of new developments in the consumer review enforcement space that may impact how you publicize and conduct your product rating and...
Continue Reading
Antitrust M&A Snapshot | Q3 2022
By Reese Poncia, Carina Kant, Jon B. Dubrow, Joel R. Grosberg and Matt Evola on Nov 18, 2022
Posted In DOJ Developments, EC Developments, EU Developments, FTC Developments, Healthcare Antitrust, Mergers & Acquisitions
In the United States, the US Department of Justice (DOJ) and the Federal Trade Commission (FTC) lost four merger challenges (Illumina/GRAIL, UnitedHealth/Change Healthcare, U.S. Sugar/Imperial Sugar and Booz Allen/EverWatch) in September. The losses demonstrate that parties willing to litigate can have success in court. The absence of “smoking gun” documents and lack of a presumption...
Continue Reading
